Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. [PDF]
Koji Yamamoto, David J. Loskutoff
openalex +1 more source
Tissue Plasminogen Activator (tPA) Use in Persistent Loculated Ascites. [PDF]
Ali KM +5 more
europepmc +1 more source
Tissue Plasminogen Activator Use in Cardiac Arrest Secondary to Fulminant Pulmonary Embolism
Tariq Yousuf +8 more
openalex +2 more sources
Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review
Abstract Chronic kidney disease (CKD) is a serious complication occurring in nearly one of three people with type 1 diabetes (T1D). Major therapeutic advances have been made in the management of CKD for people with type 2 diabetes (T2D), thereby improving their kidney, cardiovascular, and survival outcomes.
Katherine R. Tuttle +3 more
wiley +1 more source
Asparagine Endopeptidase Inhibition Attenuates Tissue Plasminogen Activator-Induced Brain Hemorrhagic Transformation After Ischemic Stroke. [PDF]
Xie G +10 more
europepmc +1 more source
This study employed GeoMx digital spatial profiling of thrombi retrieved by mechanical thrombectomy from ischemic stroke patients. Spatial transcriptomic analysis revealed distinct immune signatures, suggesting subtype‐specific mechanisms of immunothrombosis. Neutrophil extracellular trap–related pathways were enriched in cardioembolic thrombi, whereas
Sugyeong Jo +8 more
wiley +1 more source
Endovascular thrombectomy versus intravenous tissue plasminogen activator for vertebrobasilar stroke treatment: insights from the national inpatient sample. [PDF]
Saha R +6 more
europepmc +1 more source
Objective A cardiovascular safety issue has been associated with JAK inhibitors (JAKi). This study compares the effects of distinct approved JAKi on endothelial cell (EC) dysfunction and apoptosis during inflammation. Methods Massive inflammation was induced in human vascular ECs by tumor necrosis factor (TNF) with interleukin‐17A (IL‐17A) treated or ...
Aliki Zavoriti, Pierre Miossec
wiley +1 more source
Can Intrapleural Tissue Plasminogen Activator and Deoxyribonuclease Be Used to Treat Persistent Hemothorax After Robotic Lobectomy? [PDF]
Vivekanandan DD +3 more
europepmc +1 more source

